CareCloud Q2 Revenue Rises 16%, Beats Estimates; Guidance Reaffirmed
CCLD sits 25% above its 52-week low of $2.04.
Summary
CareCloud reported Q2 revenue of $31.88M, up 16% year-over-year and slightly above the $31.85M consensus. Adjusted EBITDA came in at $5.9M, down from the prior year. The company reaffirmed its full-year 2026 outlook: revenue of $128–$132M, adjusted EBITDA of $29–$31M, and GAAP EPS of $0.20–$0.23. This follows the May acquisition of Empower Healthcare, which is already contributing to growth and expanding the product portfolio into compliance and audit-defense. The reaffirmed guidance signals confidence in the integration and cross-sell potential, though the EBITDA decline warrants attention. With shares at $2.54 and a $6.00 median price target, the beat and steady outlook could support the stock.
At the time of this announcement, CCLD was trading at $2.54 on NASDAQ in the Technology sector, with a market capitalization of approximately $107.9M. The 52-week trading range was $2.04 to $4.01. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.